NOVAVAX INC revenue breakdown overview

NOVAVAX INC revenue for the last year amounted to 619.54 M CHF, the most of which — 172.75 M CHF — came from its highest performing source at the moment, Innovative Vaccines, the year earlier bringing 447.40 M CHF. The greatest contribution to the revenue figure was made by Europe — last year it brought NOVAVAX INC 84.71 M CHF, and the year before that — 225.94 M CHF.